Lupin has received approval from the UK health regulator its Goa facility.

In a regulatory filing the company stated that, it has received approval from UK MHRA (United Kingdom’s Medicines and Healthcare products Regulatory Agency) for its Goa facility. Further, this unit was inspected by UK MHRA in March 2018 and there were no critical or major observations stated.

Read EquityPandit’s Technical Analysis of Lupin